We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DB:NYSEDeutsche Bank AG Analysis

Data as of 2026-03-28 - not real-time

$28.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Deutsche Bank’s share price is trading just above the identified support level of $28.20, while remaining well below its 20‑day, 50‑day and 200‑day moving averages, indicating short‑term pressure but a potential for a technical bounce. RSI sits near the low‑30s, suggesting the stock is approaching oversold territory, and the MACD has turned bullish with the line crossing above the signal, providing a modest upside catalyst. The valuation picture is compelling: a PE of roughly 8 is less than half the industry average, the price‑to‑book of 0.58 signals a deep discount, and the discounted cash‑flow model points to a fair value near $146, implying a material upside from current levels. Dividend sustainability looks strong, with a 4.2% yield and a payout ratio under 25%, allowing investors to capture income while the stock re‑values. However, the bank faces a high beta and 30‑day volatility near 40%, reflecting sensitivity to market swings, and the sector carries inherent regulatory and geographic exposures. Overall, the combination of attractive valuation, solid dividend profile, and emerging technical support makes DB a candidate for accumulation, provided investors are comfortable with the elevated risk backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price testing near technical support
  • bullish MACD crossover
  • high dividend yield offering immediate income

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation upside versus peers
  • strong dividend sustainability with low payout ratio
  • analyst consensus of strong‑buy

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value indicating long‑term upside
  • robust operating margins and profitability
  • stable cash generation supporting future growth

Key Metrics & Analysis

Financial Health

Revenue Growth-18.80%
Profit Margin22.22%
P/E Ratio7.9
ROE8.30%
ROA0.48%
P/B Ratio0.6
Op. Cash Flow$6.8B
Industry P/E16.0

Technical Analysis

TrendNeutral
RSI32.3
Support$28.20
Resistance$34.54
MA 20$30.49
MA 50$34.78
MA 200$34.76
MACDBullish
VolumeStable
Fear & Greed Index65.98

Valuation

Fair Value$146.46
Target Price$45.00
Upside/Downside58.62%
GradeUndervalued
TypeValue
Dividend Yield4.16%

Risk Assessment

Beta1.24
Volatility39.50%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.